More Evidence Metformin May Be Neuroprotective

Stopping metformin was linked to an increased risk for dementia diagnosis in a large cohort of adults with T2D, providing more evidence of the drug’s potential neuroprotective effects.

Related Keywords

Scott Zimmerman ,Gilead Sciences ,National Institutes Of Health ,Abbott Laboratories ,Abbvie Inc ,University Of California San Francisco ,National Institute On ,Permanente Northern California ,California San Francisco ,National Institutes ,National Institute ,Alzheimers Disease ,Lzheimer Disease ,Diabetes Mellitus Type 2 ,Iabetes Mellitus Type Ii ,Type 2 Diabetes ,Dementia ,Elderly Concerns Of Older Adults , ,Kidneys ,Genomics ,Genomic Medicine ,Edicine Genomic ,Crispr ,Clustered Regularly Interspaced Short Palindromic Repeats ,Crispr Cas9 ,Geriatrics Elder Care ,Medical Records ,Records ,